EUVIMEDEUVIMED entdecken
Open Access

Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary

Mridul Sarangal

Psychopharmacology Bulletin · 29.10.2026 · 56 (4) · 153-156

DOI: 10.64719/pb.21627 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychopharmacology Bulletin, online erschienen am 29.10.2026. Verfasst von Mridul Sarangal. Beteiligte Einrichtung: Dr. Sarangal, is a third-year psychiatry resident, Department of Psychiatry and Behavioral Medicine at Carilion Clinic - Virginia Tech Carilion Schoo…. Hauptthemen laut MEDLINE: Amitriptyline, Chronic Pain, Fibromyalgia. Die Arbeit nennt 3 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To review the psychopharmacologic profile of Tonmya (cyclobenzaprine HCl sublingual tablets), FDA-approved August 15, 2025, as the first new fibromyalgia therapy in over 15 years, and provide practical guidance for integration in cases with psychiatric comorbidity. Observations Tonmya targets sleep disruption, pain, and fatigue via receptor antagonism (5-HT2A serotonergic, α1-adrenergic, H1-histaminergic, M1-muscarinic), with sublingual delivery reducing daytime sedation. Phase 3 RESILIENT trial data showed significant pain reduction (p < 0.0001, effect size 0.38 at week 14), sleep/fatigue improvements, and favorable tolerability.

Conclusions

Psychiatrists and collaborators can use Tonmya adjunctively in fibromyalgia with mood/somatic features, emphasizing patient selection, documentation, monitoring, and multidisciplinary care to minimize risks and enhance outcomes in psychosomatic pain syndromes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AmitriptylineChronic PainFibromyalgiaHumansAdministration, Sublingual

Stichwörter der Autor:innen

centralized painchronic paincyclobenzaprinefibromyalgiamood-pain overlapnon-opioid analgesicpsychopharmacologysleep disturbancesomatic symptom disordersublingual

Substanzen

Amitriptylinecyclobenzaprine

Autor:innen und Institutionen

  • Dr. Sarangal, is a third-year psychiatry resident, Department of Psychiatry and Behavioral Medicine at Carilion Clinic - Virginia Tech Carilion School of Medicine, Roanoke, Virginia.

Zitieren

APA

Sarangal, M. (2026). Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary. Psychopharmacology Bulletin, 56(4), 153-156. https://doi.org/10.64719/pb.21627

Vancouver

Sarangal M. Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary. Psychopharmacology Bulletin. 2026;56(4):153-156. doi:10.64719/pb.21627

BibTeX
@article{Sarangal2026,
  author = {Sarangal, Mridul},
  title = {Tonmya (Sublingual Cyclobenzaprine HCl) in Fibromyalgia and Chronic Pain: A Psychopharmacologic Perspective – Brief Commentary},
  journal = {Psychopharmacology Bulletin},
  year = {2026},
  volume = {56},
  number = {4},
  pages = {153--156},
  doi = {10.64719/pb.21627}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche